RecruitingPhase 1NCT06548906

A Study of GZR4 Injection at Different Injection Sites

A Trial Investigating the Pharmacokinetics, Pharmacodynamics and Safety of GZR4 Injection at Different Injection Regions in Healthy Subjects

Sponsor

Gan and Lee Pharmaceuticals, USA

Enrollment

24 participants

Start Date

May 8, 2024

Study Type

INTERVENTIONAL

Conditions

Healthy Subjects

Summary

This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).

Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called GZR4 Injection for people with healthy subjects. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.